Cargando…

Rapid Generation of Leukemogenic Chromosomal Translocations in Vivo Using CRISPR/Cas9

Detalles Bibliográficos
Autores principales:	Huang, Yun, Marovca, Blerim, Dettwiler, Susanne, Bode, Peter Karl, Bornhauser, Beat, Bourquin, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544329/ https://www.ncbi.nlm.nih.gov/pubmed/33134860 http://dx.doi.org/10.1097/HS9.0000000000000456

Ejemplares similares

LRH‐1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance
por: Michalek, Svenja, et al.
Publicado: (2022)

Induction of site-specific chromosomal translocations in embryonic stem cells by CRISPR/Cas9
por: Jiang, Junfeng, et al.
Publicado: (2016)

In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
por: Maddalo, Danilo, et al.
Publicado: (2014)

Efficient generation and reversion of chromosomal translocations using CRISPR/Cas technology
por: Lekomtsev, Sergey, et al.
Publicado: (2016)

Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support
por: Boutter, Jeannette, et al.
Publicado: (2014)

Chromosome engineering in zygotes with CRISPR/Cas9
por: Boroviak, Katharina, et al.
Publicado: (2016)

Reshuffling yeast chromosomes with CRISPR/Cas9
por: Fleiss, Aubin, et al.
Publicado: (2019)

P330: PROTEOMIC PROFILING UNCOVERS THERAPEUTIC VULNERABILITIES FOR TCF3 TRANSLOCATED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS
por: Hasselmann, Rebecca, et al.
Publicado: (2023)

CRISPR/Cas9-mediated targeted chromosome elimination
por: Zuo, Erwei, et al.
Publicado: (2017)

Chromosome drives via CRISPR-Cas9 in yeast
por: Xu, Hui, et al.
Publicado: (2020)

Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations
por: Samuelson, Clare, et al.
Publicado: (2021)

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
por: Oancea, Claudia, et al.
Publicado: (2014)

Engineering large-scale chromosomal deletions by CRISPR-Cas9
por: Eleveld, Thomas F, et al.
Publicado: (2021)

Targeted recombination of homologous chromosomes using CRISPR‐Cas9
por: Son, Wonseok, et al.
Publicado: (2023)

A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo
por: Bestas, Burcu, et al.
Publicado: (2023)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

CRISPR/Cas9 Mutagenesis by Translocation of Cas9 Protein Into Plant Cells via the Agrobacterium Type IV Secretion System
por: Schmitz, Daan J., et al.
Publicado: (2020)

Modeling of the Human Alveolar Rhabdomyosarcoma Pax3-Foxo1 Chromosome Translocation in Mouse Myoblasts Using CRISPR-Cas9 Nuclease
por: Lagutina, Irina V., et al.
Publicado: (2015)

Rapid genome editing by CRISPR-Cas9-POLD3 fusion
por: Reint, Ganna, et al.
Publicado: (2021)

Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing
por: Yin, Jianhang, et al.
Publicado: (2022)

Breakage of CRISPR/Cas9-Induced Chromosome Bridges in Mitotic Cells
por: Rodriguez-Muñoz, Marina, et al.
Publicado: (2021)

Chromosome splitting of Plasmodium berghei using the CRISPR/Cas9 system
por: Addo-Gyan, Daniel, et al.
Publicado: (2022)

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
por: Tsuchida, Connor A., et al.
Publicado: (2023)

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
por: Tsuchida, Connor A., et al.
Publicado: (2023)

CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
por: Reimer, Jana, et al.
Publicado: (2017)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
por: Dai, Wei-Jing, et al.
Publicado: (2016)

Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo
por: Yarrington, Robert M., et al.
Publicado: (2018)

In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
por: Behr, Matthew, et al.
Publicado: (2021)

Epidemiological studies of the leukemogenic effects of radiation.
por: Lilienfeld, A. M.
Publicado: (1966)

The Leukemogenic Action of Estrogens in Hybrid Mice
por: Gardner, W. U., et al.
Publicado: (1944)

Engineering new balancer chromosomes in C. elegans via CRISPR/Cas9
por: Iwata, Satoru, et al.
Publicado: (2016)

CRISPR/Cas9-mediated knock-in of the murine Y chromosomal Sry gene
por: IMAIMATSU, Kenya, et al.
Publicado: (2018)

CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
por: Cullot, Grégoire, et al.
Publicado: (2019)

Painting a specific chromosome with CRISPR/Cas9 for live-cell imaging
por: Zhou, Yuexin, et al.
Publicado: (2017)

Systematic genome editing of the genes on zebrafish Chromosome 1 by CRISPR/Cas9
por: Sun, Yonghua, et al.
Publicado: (2020)

Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells
por: Azami, Yusuke, et al.
Publicado: (2021)

Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a
por: Ishibashi, Riki, et al.
Publicado: (2022)

Rapid breeding of parthenocarpic tomato plants using CRISPR/Cas9
por: Ueta, Risa, et al.
Publicado: (2017)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uqeplv3kj7b6479o8v0mk60nv4